The implementation of surface plasmon resonance technique in monitoring pregnancies with expected fetal and neonatal alloimmune thrombocytopenia

Transfusion

Volumn 53, Issue 9, 2013, Pages 2078-2085

  Bakchoul, Tamam ^a   Bertrand, Gérald ^a   Krautwurst, Annika ^a   Kroll, Hartmut ^a   Bein, Gregor ^a   Sachs, Ulrich J ^a   Santoso, Sentot ^a   Kaplan, Cécile ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIBODY HPA1A; CORTICOSTEROID; IMMUNOGLOBULIN; MATERNAL ANTIBODY; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; BIOLOGICAL MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL BLOOD; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; OUTCOME ASSESSMENT; PREGNANCY; PRENATAL CARE; SURFACE PLASMON RESONANCE; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION;

ANTIGENS, HUMAN PLATELET; FEMALE; HUMANS; IMMUNOGLOBULINS; INFANT, NEWBORN; ISOANTIBODIES; PREGNANCY; STEROIDS; SURFACE PLASMON RESONANCE; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84883861346     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12051     Document Type: Article

References (29)

1. Bussel J, Kaplan C,. The fetal and neonatal consequences of maternal alloimmune thrombocytopenia. Baillieres Clin Haematol 1998; 11: 391-408.
2. Kaplan C,. Neonatal alloimmune thrombocytopenia: a 50-year story. Immunohematology 2007; 23: 9-13.
3. Kaplan C,. Neonatal alloimmune thrombocytopenia. Haematologica 2008; 93: 805-807.
4. Williamson LM, Hackett G, Rennie J, Palmer CR, Maciver C, Hadfield R, Hughes D, Jobson S, Ouwehand WH,. The natural history of fetomaternal alloimmunization to the platelet-specific antigen HPA-1a (PlA1, Zwa) as determined by antenatal screening. Blood 1998; 92: 2280-2287.
5. Mueller-Eckhardt C, Kiefel V, Grubert A, Kroll H, Weisheit M, Schmidt S, Mueller-Eckhardt G, Santoso S,. 348 cases of suspected neonatal alloimmune thrombocytopenia. Lancet 1989; 1: 363-366.
6. Ghevaert C, Campbell K, Walton J, Smith GA, Allen D, Williamson LM, Ouwehand WH, Ranasinghe E,. Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia. Transfusion 2007; 47: 901-910.
7. Vinograd CA, Bussel JB,. Antenatal treatment of fetal alloimmune thrombocytopenia: a current perspective. Haematologica 2010; 95: 1807-1811.
8. Daffos F, Forestier F, Kaplan C, Cox W,. Prenatal diagnosis and management of bleeding disorders with fetal blood sampling. Am J Obstet Gynecol 1988; 158: 939-946.
9. Bussel J,. Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. J Thromb Haemost 2009; 7 Suppl 1: 253-257.
10. Bussel JB, Berkowitz RL, McFarland JG, Lynch L, Chitkara U,. Antenatal treatment of neonatal alloimmune thrombocytopenia. N Engl J Med 1988; 319: 1374-1378.
11. Kaplan C,. Fetal and neonatal alloimmune thrombocytopenias. Transfus Clin Biol 2009; 16: 214-217.
12. Birchall JE, Murphy MF, Kaplan C, Kroll H,. European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. Br J Haematol 2003; 122: 275-288.
13. Bussel JB, Berkowitz RL, McFarland JG,. Maternal IVIG in neonatal alloimmune thrombocytopenia. Br J Haematol 1997; 98: 493-494.
14. Bussel JB, Berkowitz RL, Hung C, Kolb EA, Wissert M, Primiani A, Tsaur FW, Macfarland JG,. Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 2010; 203: 135.e1-e14.
15. Bussel JB, Skupski DW, Macfarland JG,. Fetal alloimmune thrombocytopenia: consensus and controversy. J Matern Fetal Med 1996; 5: 281-292.
16. Kjeldsen-Kragh J, Killie MK, Tomter G, Golebiowska E, Randen I, Hauge R, Aune B, Oian P, Dahl LB, Pirhonen J, Lindeman R, Husby H, Haugen G, Grønn M, Skogen B, Husebekk A,. A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 2007; 110: 833-839.
17. Kiefel V, Santoso S, Weisheit M, Mueller-Eckhardt C,. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies. Blood 1987; 70: 1722-1726.
18. Bertrand G, Martageix C, Jallu V, Vitry F, Kaplan C,. Predictive value of sequential maternal anti-HPA-1a antibody concentrations for the severity of fetal alloimmune thrombocytopenia. J Thromb Haemost 2006; 4: 628-637.
19. Killie MK, Husebekk A, Kaplan C, Taaning E, Skogen B,. Maternal human platelet antigen-1a antibody level correlates with the platelet count in the newborns: a retrospective study. Transfusion 2007; 47: 55-58.
20. Bessos H, Turner M, Urbaniak SJ,. Is there a relationship between anti-HPA-1a concentration and severity of neonatal alloimmune thrombocytopenia? Immunohematology 2005; 21: 102-109.
21. Bessos H, Killie MK, Seghatchian J, Skogen B, Urbaniak SJ,. The relationship of anti-HPA-1a amount to severity of neonatal alloimmune thrombocytopenia-where does it stand? Transfus Apher Sci 2009; 40: 75-78.
22. Bertrand G, Drame M, Martageix C, Kaplan C,. Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia. Blood 2011; 117: 3209-3213.
23. Bertrand G, Bakchoul T, Javela K, Kjaer KM, Kaplan C,. Interlaboratory workshop on anti-HPA-1a alloantibody quantification with the mAb-specific immobilization of platelet antigen technique. J Thromb Haemost 2012; 10: 1172-1174.
24. Socher I, Ndrei-Selmer C, Bein G, Kroll H, Santoso S,. Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion 2009; 49: 943-952.
25. Bakchoul T, Kubiak S, Krautwurst A, Roderfeld M, Siebert HC, Bein G, Sachs UJ, Santoso S,. Low-avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion 2011; 51: 2455-2461.
26. Griffin HM, Ouwehand WH,. A human monoclonal antibody specific for the leucine-33 (P1A1, HPA-1a) form of platelet glycoprotein IIIa from a V gene phage display library. Blood 1995; 86: 4430-4436.
27. Killie MK, Husebekk A, Kjeldsen-Kragh J, Skogen B,. A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica 2008; 93: 870-877.
28. Malek A, Sager R, Kuhn P, Nicolaides KH, Schneider H,. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996; 36: 248-255.
29. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M,. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; 2012: 985646.